Description

2-(4-Methoxyphenyl)-2,7-Diazaspiro[4.4]Nonan-3-One is a high-purity, advanced pharmaceutical intermediate featuring a unique spirocyclic diaza structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel, biologically active molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within central nervous system (CNS) and oncology drug discovery pipelines.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used extensively in structure-activity relationship (SAR) studies and lead optimization processes due to its versatile spirocyclic scaffold.
• CNS Drug Development: Employed in the research and development of novel therapeutics for neurological and psychiatric disorders.
• Oncology Research: Utilized as a building block for creating compounds screened for anti-cancer activity.
• Chemical Biology Probes: Acts as a core structure for developing tool compounds to study specific biological targets and mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical innovation for client projects.

Basic Information

Product Name	2-(4-Methoxyphenyl)-2,7-Diazaspiro[4.4]Nonan-3-One
CAS No.	1422067-41-1
Molecular Formula	C15H20N2O2
Molecular Weight	260.33 g/mol
Synonyms	2-(4-Methoxyphenyl)-2,7-diazaspiro[4.4]nonan-3-one; 2-(4-Methoxyphenyl)-2,7-diazaspiro[4.4]nonane-3-one; 2,7-Diazaspiro[4.4]nonan-3-one, 2-(4-methoxyphenyl)-; UNII-8C6J2G3Y8Q; 8C6J2G3Y8Q; 1422067-41-1; AKOS040745176; 2-(4-methoxyphenyl)-2,7-diazaspiro[4.4]nonan-3-one
EINECS	Contact for details

Quality Control

Our 2-(4-Methoxyphenyl)-2,7-Diazaspiro[4.4]Nonan-3-One is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to relevant ICH guidelines and can support development projects requiring material produced under cGMP conditions for advanced clinical stages.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.